Evidence records
Enlivex — Wikidata Q96480089 evidence
Enlivex — Wikidata Q96480089; Israeli drug company, focused on Cell Immunotherapy; source revision 2403514555, modified 2025-09-11T10:32:09Z.
Evidence records
The details below reflect the retained source records. Follow the references to check their context; missing information is not filled in.
Source description
Israeli drug company, focused on Cell Immunotherapy
Sourcewww.wikidata.orgSource-listed website
www.enlivex.com — https://www.enlivex.com
Sourcewww.wikidata.orgWikidata item
Wikidata Q96480089
Sourcewww.wikidata.orgSource revision
2403514555, modified 2025-09-11T10:32:09Z
Sourcewww.wikidata.org
Continue exploring
About these subjects
Related source records
Data & record details
Download the same cited information as JSON. The revision identifiers below distinguish changes to the facts from changes to the subjects included.
Download this recordapplication/json
- Surface ID
- urn:readyscan:corpus:evidence:enlivex-q96480089
- Material fingerprint
- fnv1a64:e37a0d24315cc87d
- Membership fingerprint
- fnv1a64:085b68d7ae2f8113
- Published
- 2026-07-29
- Modified
- 2026-07-29